Search

Search Results

• 

  Influenza vaccination is safe and effective in patients suffering from fibromyalgia syndrome

  J. N. Ablin, V. Aloush, A. Brill, M. Berman, M. Barzilai, D. Caspi, M. Mandelboim, D. Levartovsky, A. Polachek, Y. Wolman, D. Paran, M. Barkagan, O. Elkayam

  57-61

  16-09-2015

  https://doi.org/10.4081/reumatismo.2015.823

  2347

  PDF: 1093
• 

  Adherence to vaccination against SARS-CoV-2 and vaccine safety in patients with IgG4-related disease

  Linda Mastromanno, Federico Giardina, Angelica Gattamelata, Serena Colafrancesco, Simona Truglia, Francesca Romana Spinelli, Edoardo Simoncelli, Bruno Lucchino, Fabrizio Conti, Roberta Priori

  22-01-2025

  https://doi.org/10.4081/reumatismo.2025.1744

  1438

  PDF: 139

  SUPPLEMENTARY MATERIAL: 53
• 

  Idiopathic inflammatory myopathies linked to vaccination against SARS-CoV-2: a systematic review

  A. Camargo-Coronel, H. Quiñones-Moya; M.R. Hernández-Zavala; J.R. Hernández-Vázquez, M.Á. Vázquez-Zaragoza

  08-05-2023

  https://doi.org/10.4081/reumatismo.2023.1548

  2117

  PDF: 1584

• PO:17:248 | Prevention of human papillomavirus infection in women with systemic lupus erythematosus: a single-center cross-sectional study Clizia Gagliardi¹, Maria Chiara Gerardi¹, Bianca Lucia Palermo¹, Giulia Carrea¹, Maria Di Cicco¹, Elena Manna¹, Giulia Segatto¹, Antonella Adinolfi¹, Laura Belloli¹, Cinzia Casu¹, Silvia Cavalli¹, Davide Antonio Filippini¹, Matteo Longhi¹, Gabriella Maioli¹, Martina Schettino¹, Nicola Ughi¹, Elisa Verduci¹, Arianna Bertolucci¹, Lara Buffa¹, Giulia Buonsante¹, Claudia Cordini¹, Eleonora Giacobbe¹, Francesco Molica Colella¹, Oscar Epis¹ | ¹ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

  Società Italiana di Reumatologia

  26-11-2025

  https://doi.org/10.4081/reumatismo.2025.2165

  71
• 

  Disseminated cutaneous herpes simplex infection after COVID-19 vaccination in a rheumatoid arthritis patient: a case report and review

  D. Mohamadzadeh, S. Assar, M. Pournazari, P. Soufivand, S. Danaei

  13-09-2022

  https://doi.org/10.4081/reumatismo.2022.1489

  1873

  PDF: 1125
• 

  Erythema nodosum after COVID-19 vaccine

  B. Maranini, G. Ciancio, M. Corazza, F. Ruffilli, G. Galoppini, M. Govoni

  03-05-2022

  https://doi.org/10.4081/reumatismo.2022.1475

  2818

  PDF: 1182

• PO:17:250 | Effectiveness and safety of the recombinant zoster vaccine in patients ≥18 years of age with systemic lupus Giulia Boschi¹, Sheryl A. Kluberg², Sophie E. Mayer², O'Mareen Spence³, Driss Oraichi³, Harry Seifert³, Omar Ali³, Huifeng Yun³, Andrew L. Simon⁴, Jenice S. Ko⁴, Caroline Hugh⁴, Meg Her⁴, Kathleen Shattuck⁴, Richard Platt², Aziza Jamal-Allial⁵, Djeneba Audrey Djibo⁶, Kimberly Daniels⁵, Qianli Ma⁷, Cheryl N. Mcmahill-Walraven⁶, Rachel P. Ogilvie⁸, Kristin Palmsten⁹, Mano Selvan⁷, Najat Ziyadeh⁸, Alexis Ogdie¹⁰, Michael George¹⁰ | ¹GSK Verona Italy; ²Harvard Medical School and the Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston; ³GSK Rockville; ⁴Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston; ⁵Carelon Research, Wilmington; ⁶CVS Health, Blue Bell; ⁷Humana Healthcare Research, Louisville; ⁸OptumInsight Life Sciences, Boston; ⁹HealthPartners Institute, Bloomington; ¹⁰University of Pennsylvania, Philadelphia, USA

  Società Italiana di Reumatologia

  26-11-2025

  https://doi.org/10.4081/reumatismo.2025.2166

  74
• 

  Vaccination of mice for research purpose: alum is as effective as and safer than complete Freund adjuvant

  N. Bassi, R. Luisetto, A. Ghirardello, M. Gatto, B. Bottazzi, Y. Shoenfeld, L. Punzi, A. Doria

  380-387

  20-12-2012

  https://doi.org/10.4081/reumatismo.2012.380

  2463

  PDF: 1010

• PO:08:114 | The adjuvanted recombinant zoster vaccine is effective in preventing herpes zoster among patients ≥50 years of age with selected autoimmune diseases in the united states: a real-world database analysis (2018–2021) Rosaria Silvestri¹, Dagna Constenla², Germain Lonnet³, Emmanuel Aris³, Nathalie Servotte³, Ramsanjay Rk⁴, Agnes Mwakingwe-Omari², Huifeng Yun² | ¹GSK Verona, Italy; ²GSK Rockville, USA; ³GSK Wavre, Belgium; ⁴GSK Bengaluru, India

  Società Italiana di Reumatologia

  26-11-2025

  https://doi.org/10.4081/reumatismo.2025.2140

  78
• 

  Myositis after SARS-CoV-2 vaccination occurs more frequently than assumed and is probably causally related

  J. Finsterer, A.S. MohanaSundaram, F. Scorza

  18-09-2023

  https://doi.org/10.4081/reumatismo.2023.1601

  1394

  PDF: 484
• 

  Response to: myositis after SARS-CoV-2 vaccination occurs more frequently than assumed and is probably causally related

  H. Quiñones-Moya, A. Camargo-Coronel, M.R. Hernández-Zavala

  18-09-2023

  https://doi.org/10.4081/reumatismo.2023.1623

  1030

  PDF: 346
• 

  Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab

  J. Finsterer

  03-05-2022

  https://doi.org/10.4081/reumatismo.2022.1474

  2065

  PDF: 572
• 

  Reply to: “Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab” by Josef Finsterer

  B. Maranini, G. Ciancio, R. Cultrera, M. Govoni

  03-05-2022

  https://doi.org/10.4081/reumatismo.2022.1482

  2304

  PDF: 669
• 

  Comment to: Disseminated cutaneous herpes simplex, COVID-19 vaccination and rheumatoid arthritis patient: a case report and review

  B. Joob, V. Wiwanitkit

  29-12-2022

  https://doi.org/10.4081/reumatismo.2022.1527

  856

  PDF: 381
• 

  Patients with systemic lupus erythematosus and their experience with vaccination against COVID-19: a descriptive and explanatory study

  F. Ceccarelli, V. Covelli, G. Olivieri, F. Natalucci, C. Alessandri, F. Conti

  13-09-2022

  https://doi.org/10.4081/reumatismo.2022.1491

  1243

  PDF: 592